← Leaderboards
Frank Scott Lieberman
Mount Sinai School Of Medicine Of Cuny
$530,759
Attributed
$530,759
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $81.9K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$530,759 · 7
By mechanism
U01$434,893 · 1
M01$95,866 · 6
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationClinical Trial Phase INeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer ChemotherapyGliomaClinical Trial Phase IiPatient Oriented ResearchBrain NeoplasmsTissue Resource /RegistryAntineoplasticsClinical TrialsNeoplasm /Cancer PharmacologyGlioblastoma MultiformeGene TherapyTemozolomidePharmacokineticsNeuropathologyDosageCooperative StudyNeoplasm /Cancer Radiation TherapyCancer Therapy Evaluation ProgramCancer Therapy
Grant awards (16)
NABTC Member Institution Grant (UCSF Project Leader)$58,706
U01 · FY2008 · CA · contact PI
NABTC Member Institution Grant (UCSF Project Leader)$40,448
U01 · FY2007 · CA · contact PI
NABTC Member Institution Grant (UCSF Project Leader)$44,057
U01 · FY2006 · CA · contact PI
NABTC Member Institution Grant (UCSF Project Leader)$69,593
U01 · FY2005 · CA
PH I/II TRIAL OSI-774 PTS W/RECURR MALIG GLIOMAS &MALIG GLIOMAS POST RADIATN$9,660
M01 · FY2005 · RR
PHI/II TRIAL OF R115777 IN PTS W/RECURRENT MALIGNANT GLIOMA$1,666
M01 · FY2005 · RR
PH II TRL OF EMD 121974 RCURRENT GLIOBLASTOMA CLIN TRIAL W/TISSUE CORRELATE RESP$999
M01 · FY2005 · RR
NABTC Member Institution Grant (UCSF Project Leader)$67,568
U01 · FY2004 · CA
PH I/II Trial OSI-774 Pts w/Recurr. Malig. Gliomas$10,938
M01 · FY2004 · RR
PHI/II Trial CPT-11/Temozolomide in Malignant Glioma$2,798
M01 · FY2004 · RR
PHI/II ZD1839 in Subj w/Recurr. Malig. Glioma Meningiomas$1,017
M01 · FY2004 · RR
NABTC MEMBER INSTITUTION GRANT (UCSF PROJECT LEADER)$100,086
U01 · FY2003 · CA
NABTC MEMBER INSTITUTION GRANT (UCSF PROJECT LEADER)$54,435
U01 · FY2002 · CA
GENE THERAPY FOR RECURRENT GLIOBLASTOMA MULTIFORME--PHASE I TRIAL$0
M01 · FY2002 · RR
GENE THERAPY FOR RECURRENT GLIOBLASTOMA MULTIFORME--PHASE I TRIAL$0
M01 · FY2001 · RR
GENE THERAPY FOR RECURRENT GLIOBLASTOMA MULTIFORME--PHASE I TRIAL$68,788
M01 · FY2000 · RR